After studies in Canada linked Trasylol to a higher chance of death, the drug has been removed from marketing. Trasylol is used because it slows down the breakdown of blood clots during surgery. Bayer AG, the drug's pharmaceutical firm, was faulted for not mentioning studies that said that the drug was more dangerous then other antifibrinolytic drugs.
Read More...
[Source: Article Node RSS Feed of Free Re-Print Articles - Posted by FreeAutoBlogger]